OABI Q3 2021 Earnings — OmniAb, Inc. Revenue & Financial Results | Market Cap Arena

OABIOmniAb, Inc.

$221M

Q3 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$6M+25.9% YoY

Gross Profit

$6M100.0% margin

Operating Income

-$10M-156.2% margin

Net Income

-$8M-125.7% margin

EPS (Diluted)

$-0.00

QoQ Revenue Growth

+12.4%

Cash Flow

Operating Cash Flow

-$966,377

Free Cash Flow

-$966,380

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$283M

Total Liabilities

$55M

Stockholders' Equity

$228M

Cash & Equivalents

$0

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$6M	$5M	+25.9%
Gross Profit	$6M	$5M	+25.9%
Operating Income	-$10M	-$8M	-18.1%
Net Income	-$8M	-$7M	-18.0%